Skandinaviska Enskilda Banken AB (publ) - IMPAX LABORATORIES INC ownership

IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 180 filers reported holding IMPAX LABORATORIES INC in Q1 2017. The put-call ratio across all filers is 0.50 and the average weighting 0.1%.

Quarter-by-quarter ownership
Skandinaviska Enskilda Banken AB (publ) ownership history of IMPAX LABORATORIES INC
ValueSharesWeighting
Q4 2017$1,568,000
+785.9%
94,200
+756.4%
0.01%
+550.0%
Q2 2017$177,000
-81.5%
11,000
-85.4%
0.00%
-50.0%
Q1 2017$956,000
-75.4%
75,600
-74.2%
0.00%
-91.5%
Q4 2016$3,884,000
-20.6%
293,100
+42.0%
0.05%
-11.3%
Q3 2016$4,892,000
-3.7%
206,400
+17.1%
0.05%
-7.0%
Q2 2016$5,078,000
-1.7%
176,200
+9.2%
0.06%
-1.7%
Q1 2016$5,165,000
-37.2%
161,300
-16.1%
0.06%
-45.8%
Q4 2015$8,223,000192,3000.11%
Other shareholders
IMPAX LABORATORIES INC shareholders Q1 2017
NameSharesValueWeighting ↓
NEXTHERA CAPITAL LP 560,400$9,022,0003.93%
NORTH TIDE CAPITAL, LLC 1,000,000$16,100,0003.58%
Sivik Global Healthcare LLC 250,000$4,025,0001.47%
MAVERICK CAPITAL LTD 7,159,336$115,265,0001.44%
SECTOR GAMMA AS 589,311$9,488,0001.38%
BRIDGER MANAGEMENT, LLC 1,341,143$21,592,0001.23%
Eos Focused Equity Management, L.P. 48,714$784,0000.89%
Bridge City Capital, LLC 47,194$760,0000.64%
Fosun International Ltd 300,000$4,830,0000.60%
Century Capital Management, LLC 203,138$3,271,0000.56%
View complete list of IMPAX LABORATORIES INC shareholders